|
1) Orford KW, Scadden DT. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat Rev Genet. 2008; 9: 115-28
|
|
|
|
2) Taniguchi T, Ogasawara K, Takaoka A, et al. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol. 2001; 19: 623-55
|
|
|
|
|
|
3) Hida S, Ogasawara K, Sato K, et al. CD8(＋)T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. Immunity. 2000; 13: 643-55
|
|
|
|
|
|
4) Ichikawa E, Hida S, Omatsu Y, et al. Defective development of splenic and epidermal CD4＋ dendritic cells in mice deficient for IFN regulatory factor-2. Proc Natl Acad Sci U S A. 2004; 101: 3909-14
|
|
|
|
|
|
5) Mizutani T, Tsuji K, Ebihara Y, et al. Homeostatic erythropoiesis by the transcription factor IRF2 through attenuation of type I interferon signaling. Exp Hematol. 2008; 36: 255-64
|
|
|
|
|
|
6) Liu XL, Yuan JY, Zhang JW, et al. Differential gene expression in human hematopoietic stem cells specified toward erythroid, megakaryocytic, and granulocytic lineage. J Leukoc Biol. 2007; 82: 986-1002
|
|
|
|
|
|
7) Masumi A, Hamaguchi I, Kuramitsu M, et al. Interferon regulatory factor-2 induces megakaryopoiesis in mouse bone marrow hematopoietic cells. FEBS Lett. 2009; 583: 3493-500
|
|
|
|
|
|
8) Sato T, Onai N, Yoshihara H, et al. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat Med. 2009; 15: 696-700
|
|
|
|
|
|
9) Taniguchi T, Takaoka A. A weak signal for strong responses: interferon-alpha/beta revisited. Nat Rev Mol Cell Biol. 2001; 2: 378-86
|
|
|
|
|
|
10) Yoshihara H, Arai F, Hosokawa K, et al. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell. 2007; 1: 685-97
|
|
|
|
|
|
11) Essers MA, Offner S, Blanco-Bose WE, et al. IFN alpha activates dormant haematopoietic stem cells in vivo. Nature. 2009; 458: 904-8
|
|
|
|
|